Home > Insider Trading > Filing (0001615774-18-014984)

Filing Details

Accession Number:: 0001615774-18-014984
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-26 17:14:18
Reporting Period:: 2018-12-24

Accepted Time:: 2018-12-26 17:14:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1686850	Motus Gi Holdings Inc.	MOTS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292834	P David Hochman	C/O Motus Gi Holdings, Inc. 1301 East Broward Boulevard, 3Rd Floor Ft. Lauderdale, FL 33301		Yes	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2018-12-24	20,000	$2.70	100,000	No	4	P	Indirect	By DPH 2008 Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By DPH 2008 Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	18,000	Direct
Common Stock, Par Value $0.0001 Per Share	109,792	Indirect	By Orchestra Medical Ventures II, L.P.
Common Stock, Par Value $0.0001 Per Share	2,000,000	Indirect	By Orchestra BioMed, Inc.
Common Stock, Par Value $0.0001 Per Share	1,159,968	Indirect	By Orchestra MOTUS Co-Investment Partners, LLC
Common Stock, Par Value $0.0001 Per Share	83,352	Indirect	By Orchestra Medical Ventures II Reserve, L.P.
Common Stock, Par Value $0.0001 Per Share	51,498	Indirect	By Accelerated Technologies, Inc.

Footnotes

The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on December 24, 2018.
The securities are directly held by Orchestra Medical Ventures II, L.P. ("OMV II"). Orchestra Medical Ventures II GP, LLC ("OMV GP") serves as general partner to OMV II. Reporting Person and Darren Sherman are the managing members of OMV GP. Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by OMV II. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
The securities are directly held by Orchestra BioMed, Inc., a Delaware corporation ("OBIO"). Reporting Person, Mr. Sherman and Geoffrey W. Smith are the directors of OBIO. Reporting Person, Mr. Sherman and Mr. Smith jointly exercise dispositive and voting power over the shares owned by OBIO. Each of Reporting Person, Mr. Sherman and Mr. Smith disclaim, for purposes of Section 16, beneficial ownership of such securities, except to the extent of their indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or Mr. Smith are the beneficial owners of such securities for purposes of Section 16 or for any other purposes.
The securities are directly held by Orchestra MOTUS Co-Investment Partners, LLC ("OMCP"). Orchestra Medical Ventures, LLC ("OMV LLC") serves as managing member to OMCP. Reporting Person and Mr. Sherman are the managing partners of OMV LLC. Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by OMCP. Each of Reporting Person, Mr. Sherman and OMV LLC disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
The securities are directly held by Orchestra Medical Ventures II Reserve, L.P. ("OMV Reserve"). OMV GP serves as general partner to OMV Reserve. Reporting Person and Mr. Sherman are the managing members of OMV GP. Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by OMV Reserve. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
The securities are directly held by Accelerated Technologies, Inc. ("ATI"). Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by ATI. Each of Reporting Person and Mr. Sherman disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person or Mr. Sherman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.